DailyDoctor Archive Specialties Get app
Back to the 30 October 2026 edition

Clinical update · 01 of 06

Low-dose esketamine cut chronic pain three months after thoracoscopic lung resection

Consider low-dose perioperative esketamine for thoracoscopic lung resection to reduce chronic postsurgical pain.

Design
Multicentre randomised, double-blind, placebo-controlled trial
Population
873 adults having video-assisted thoracoscopic lung resection
Primary outcome
Chronic pain at 3 months (any pain on coughing)
Effect
14.7% vs 21.2%; adjusted OR 0.62 (95% CI 0.43-0.90)

Chronic pain remains common after video-assisted thoracoscopic surgery. This multicentre double-blind trial randomised 914 adults to esketamine or saline: a 0.1 mg/kg bolus at induction, 0.1 mg/kg/h during surgery and 0.015 mg/kg/h for 48 hours afterwards.

Among 873 patients analysed, chronic pain at three months (any pain on coughing at the surgical site) occurred in 14.7% with esketamine and 21.2% with saline (adjusted OR 0.62, 95% CI 0.43-0.90). A stricter post hoc definition of moderate pain pointed the same way. Esketamine also lowered pain scores and analgesic use in the first 48 hours, without more adverse events.

The primary definition counts any pain at all, which sets a low bar; the post hoc moderate-pain result is weaker evidence. Esketamine is not available everywhere, and racemic ketamine dosing does not translate directly.

Where esketamine is available, a low-dose perioperative infusion is a reasonable addition to multimodal analgesia for thoracoscopic lung resection.

  • Esketamine 0.1 mg/kg bolus, 0.1 mg/kg/h in theatre and 0.015 mg/kg/h for 48 hours was the regimen tested.
  • Chronic pain at three months fell from 21.2% to 14.7%.
  • Early pain scores and analgesic use were also lower, with no excess adverse events.
  • Consider adding it to multimodal analgesia for thoracoscopic lung resection.
  • Do not convert this regimen directly to racemic ketamine doses.

Why it matters

Chronic pain after a short-stay thoracoscopic operation is often missed because patients have left the anaesthetist's care long before it shows.

Don't overread it

The primary outcome counted any pain on coughing; the moderate-pain result was defined after the trial.

The statistics, in plain English

An adjusted odds ratio of 0.62 means about 40% lower odds of chronic pain; the interval stays below 1. In absolute terms, about one patient in 15 avoided chronic pain.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

chronicpainacutepainperioperativeregionalanaesgeneralanaes

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app